Cardiac implantable electronic devices (CIEDs) constitute a major breakthrough in the management of heart rhythm disorders. These devices largely include bradycardia pacemakers, biventricular ...

Left ventricular systolic dysfunction (LVSD) was common in patients receiving right ventricular pacing, and a history of ischaemic heart disease and a high ventricular pacing burden were identified as ...

The FDA has approved EBR’s WISE device, the world’s only leadless pacemaker for left-ventricle stimulation The company will undergo a cautious staged rollout in the US$3.6 billion-a-year US ...

The rhythm is regular at a rate of 120 beats/min. A pacemaker stimulus occurs before each QRS complex (→). This is ventricular pacing. Because the pacing rate is 120 beats/min, the mode of pacing must ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s smallest, wireless, implantable device for cardiac pacing, today announced the U.S. Food and Drug Administration has ...

New Evidence Further Defines Distinct Clinical Considerations for Transcatheter Aortic Valve Replacement (TAVR) in Aortic Regurgitation (AR) and Advances Understanding of the Trilogy® System in ...

This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...

A biventricular pacemaker is a device that can help the heart beat more efficiently when a person has heart failure or an irregular heartbeat. When a person has heart failure or an irregular heartbeat ...

The cardiac pacemaker harmlessly dissolves over the course of 35 days. (Courtesy: Northwestern University) Temporary cardiac pacemakers provide essential pacing for patients with short-term heart ...

Please provide your email address to receive an email when new articles are posted on . Wireless pacemakers may be a safe and effective short-term option for children requiring permanent pacing.